Home

Gloed Heer Groenland rela nf kappa b amyotrophic lateral sclerosis pubmed Veel Diagnostiseren blaas gat

NF‐κB activation in astrocytes drives a stage‐specific beneficial  neuroimmunological response in ALS | The EMBO Journal
NF‐κB activation in astrocytes drives a stage‐specific beneficial neuroimmunological response in ALS | The EMBO Journal

Purinergic P2X7 Receptor: A Therapeutic Target in Amyotrophic Lateral  Sclerosis | ACS Chemical Neuroscience
Purinergic P2X7 Receptor: A Therapeutic Target in Amyotrophic Lateral Sclerosis | ACS Chemical Neuroscience

IJMS | Free Full-Text | Heterogeneity of Neuroinflammatory Responses in Amyotrophic  Lateral Sclerosis: A Challenge or an Opportunity?
IJMS | Free Full-Text | Heterogeneity of Neuroinflammatory Responses in Amyotrophic Lateral Sclerosis: A Challenge or an Opportunity?

Frontiers | What Is Nuclear Factor Kappa B (NF-κB) Doing in and to the  Mitochondrion?
Frontiers | What Is Nuclear Factor Kappa B (NF-κB) Doing in and to the Mitochondrion?

GSK-3β controls NF-kappaB activity via IKKγ/NEMO | Scientific Reports
GSK-3β controls NF-kappaB activity via IKKγ/NEMO | Scientific Reports

IJMS | Free Full-Text | The Links between ALS and NF-κB
IJMS | Free Full-Text | The Links between ALS and NF-κB

State of play in amyotrophic lateral sclerosis genetics | Nature  Neuroscience
State of play in amyotrophic lateral sclerosis genetics | Nature Neuroscience

Non-neuronal cells in amyotrophic lateral sclerosis — from pathogenesis to  biomarkers | Nature Reviews Neurology
Non-neuronal cells in amyotrophic lateral sclerosis — from pathogenesis to biomarkers | Nature Reviews Neurology

The acetylation of RelA in Lys310 dictates the NF-κB-dependent response in  post-ischemic injury | Cell Death & Disease
The acetylation of RelA in Lys310 dictates the NF-κB-dependent response in post-ischemic injury | Cell Death & Disease

Symptoms timeline and outcomes in amyotrophic lateral sclerosis using  artificial intelligence | Scientific Reports
Symptoms timeline and outcomes in amyotrophic lateral sclerosis using artificial intelligence | Scientific Reports

Stress Granule Homeostasis, Aberrant Phase Transition, and Amyotrophic  Lateral Sclerosis | ACS Chemical Neuroscience
Stress Granule Homeostasis, Aberrant Phase Transition, and Amyotrophic Lateral Sclerosis | ACS Chemical Neuroscience

Recent advances in the diagnosis and prognosis of amyotrophic lateral  sclerosis - The Lancet Neurology
Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis - The Lancet Neurology

Acetylation state of RelA modulated by epigenetic drugs prolongs survival  and induces a neuroprotective effect on ALS murine model | Scientific  Reports
Acetylation state of RelA modulated by epigenetic drugs prolongs survival and induces a neuroprotective effect on ALS murine model | Scientific Reports

Frontiers | Key Disease Mechanisms Linked to Amyotrophic Lateral Sclerosis  in Spinal Cord Motor Neurons
Frontiers | Key Disease Mechanisms Linked to Amyotrophic Lateral Sclerosis in Spinal Cord Motor Neurons

TAZ ameliorates the microglia-mediated inflammatory response via the  Nrf2-ROS-NF-κB pathway: Molecular Therapy - Nucleic Acids
TAZ ameliorates the microglia-mediated inflammatory response via the Nrf2-ROS-NF-κB pathway: Molecular Therapy - Nucleic Acids

Multitarget Hybrid Fasudil Derivatives as a New Approach to the Potential  Treatment of Amyotrophic Lateral Sclerosis | Journal of Medicinal Chemistry
Multitarget Hybrid Fasudil Derivatives as a New Approach to the Potential Treatment of Amyotrophic Lateral Sclerosis | Journal of Medicinal Chemistry

Cells | Free Full-Text | The NF-κB Pathway and Cancer Stem Cells
Cells | Free Full-Text | The NF-κB Pathway and Cancer Stem Cells

Gene therapy for ALS: A review: Molecular Therapy
Gene therapy for ALS: A review: Molecular Therapy

Frontiers | Synergistic association of resveratrol and histone deacetylase  inhibitors as treatment in amyotrophic lateral sclerosis
Frontiers | Synergistic association of resveratrol and histone deacetylase inhibitors as treatment in amyotrophic lateral sclerosis

Cells | Free Full-Text | Aberrant Activation of NF-κB Signalling in  Aggressive Lymphoid Malignancies
Cells | Free Full-Text | Aberrant Activation of NF-κB Signalling in Aggressive Lymphoid Malignancies

Frontiers | Protective role of ethyl pyruvate in spinal cord injury by  inhibiting the high mobility group box-1/toll-like receptor4/nuclear factor-kappa  B signaling pathway
Frontiers | Protective role of ethyl pyruvate in spinal cord injury by inhibiting the high mobility group box-1/toll-like receptor4/nuclear factor-kappa B signaling pathway

Frontiers | Neuronal Gene Targets of NF-κB and Their Dysregulation in  Alzheimer's Disease
Frontiers | Neuronal Gene Targets of NF-κB and Their Dysregulation in Alzheimer's Disease

Cells | Free Full-Text | Challenges with Methods for Detecting and Studying  the Transcription Factor Nuclear Factor Kappa B (NF-κB) in the Central  Nervous System
Cells | Free Full-Text | Challenges with Methods for Detecting and Studying the Transcription Factor Nuclear Factor Kappa B (NF-κB) in the Central Nervous System

Frontiers | The Safety and Efficacy of Stem Cell Therapy as an Emerging  Therapy for ALS: A Systematic Review of Controlled Clinical Trials
Frontiers | The Safety and Efficacy of Stem Cell Therapy as an Emerging Therapy for ALS: A Systematic Review of Controlled Clinical Trials